The information highlighted (if any) are the most recent updates for this brand.
Hypersensitivity to lorlatinib or to any of the excipients listed (Microcrystalline cellulose; Dibasic calcium phosphate anhydrous/Calcium hydrogen phosphate; Sodium starch glycolate; Magnesium stearate, Hydroxypropyl methylcellulose (HPMC)/Hypromellose; Lactose monohydrate; Macrogol/Polyethylene glycol (PEG) 3350; Triacetin; Titanium dioxide; Ferrosoferric oxide/Iron oxide black; Iron oxide red). Concomitant use of strong CYP3A inducers with lorlatinib is contraindicated due to the potential for serious hepatotoxicity (aspartate aminotransferase [AST] and alanine aminotransferase [ALT] elevations).
Sign Out
